Dimethyl dimethoxy biphenyl dicarboxylate attenuates hepatic and metabolic alterations in high fructose-fed rats

In conclusion, DDB ameliorates high fructose-induced metabolic disorders and hepatic steatosis in rats. Such protection is, at least in part, due to the inhibition of lipid peroxidation, decrease in iNOS overexpression, and reduction of elevated uric acid.

Source: Toxicology and Industrial Health - December 31, 2015 Category: Toxicology Authors: Morsy, M. A., Ibrahim, M. A., Abd-Elghany, M. I. Tags: Articles Source Type: research